Cholesterol-lowering statins, used by millions of Americans to treat and prevent atherosclerosis, may falsely indicate thyroid problems, according to researchers at Texas Health Presbyterian Hospital Dallas. Their study, Radioiodine studies, low serum TSH, and the influence of statin drugs, appears in the journal Thyroid.
"These findings could help physicians make quicker, more accurate diagnoses of suspected thyroid problems," said William Harvey, a nuclear medicine physician and author of the study. "It also has very provocative scientific implications as we learn more about how statins affect different systems in the body," he added.
The researchers re-examined 307 patients whose initial TSH blood tests, the most common measure of thyroid function, showed overactive thyroids. Symptoms of the condition, called hyperthyroidism, can include a fast heart rate and palpitations, tremors, anxiety, weak muscles and difficulty sleeping.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze